Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets (Parenthetical)

v3.8.0.1
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Restricted cash $ 46,012 $ 46,106
Notes receivable, net $ 431,801 $ 430,480
Common Stock, par value $ 0.01 $ 0.01
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 74,734,455 70,997,732
Common stock, shares outstanding 74,734,455 70,997,732
Variable Interest Entity, Primary Beneficiary [Member]    
Restricted cash $ 19,488 $ 21,894
Notes receivable, net $ 282,599 $ 287,012